Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is neopterin level a predictive and differential biomarker in patients with thyroid disorders?

Literature DB >> 19411813

Is neopterin level a predictive and differential biomarker in patients with thyroid disorders?

T T Sahin¹, O Yuksel, G Girgin, H Sipahi, K Dikmen, C Azili, F Taneri, T Baydar.

Abstract

Neopterin production provides information about the extent of cellular immune activation. Measurement of neopterin levels may also provide predictive and prognostic information in patients with malignant thyroid diseases. In the present study, neopterin levels were investigated in patients with thyroid disorders (no.=68). Twenty-four patients had papillary thyroid cancers and the rest of them benign thyroid disorders. Results were compared with a healthy control group (no.=30). It was observed that there was a significant difference in neopterin levels between the control group and the thyroid disorders group (p<0.05). The mean neopterin levels in malignant and benign patients were also significantly different (p<0.05). Monitoring of urinary neopterin profile may be used in early diagnosis of papillary thyroid cancer. Neopterin seems to be a differential biomarker for malignant and benign thyroid disorders.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2009 PMID： 19411813 DOI： 10.1007/BF03345704

Source DB: PubMed Journal: J Endocrinol Invest ISSN： 0391-4097 Impact factor: 4.256

17 in total

1. Effect of aluminum exposure on pteridine metabolism.

Authors: T Baydar; A B Engin; A Aydin; G Sahin
Journal: Biol Trace Elem Res Date: 2005-08 Impact factor: 3.738

Review 2. Neopterin as a marker for immune system activation.

Authors: C Murr; B Widner; B Wirleitner; D Fuchs
Journal: Curr Drug Metab Date: 2002-04 Impact factor: 3.731

Review 3. Neopterin measurement in clinical diagnosis.

Authors: A Berdowska; K Zwirska-Korczala
Journal: J Clin Pharm Ther Date: 2001-10 Impact factor: 2.512

4. A comparative study of urinary xanthopterin and neopterin in liver diseases.

Authors: A Fukuda; T Mazda; W L Gyure; T Iino; H Harada; M Yakura; H Kamitsukasa; A Ohbayashi; T Oka; M Tsusué
Journal: Eur J Clin Chem Clin Biochem Date: 1993-03

5. Increased serum neopterin levels in patients with Graves' disease.

Authors: R Wagner; S Hayatghebi; M Rosenkranz; D Reinwein
Journal: Exp Clin Endocrinol Date: 1993

Review 6. Neopterin as a marker for activated cell-mediated immunity: application in malignant disease.

Authors: G Reibnegger; D Fuchs; L C Fuith; A Hausen; E R Werner; G Werner-Felmayer; H Wachter
Journal: Cancer Detect Prev Date: 1991

Review 7. Potential role of immune system activation-associated production of neopterin derivatives in humans.

Authors: G Hoffmann; B Wirleitner; D Fuchs
Journal: Inflamm Res Date: 2003-08 Impact factor: 4.575

8. Neopterin as a new biomarker for the evaluation of occupational exposure to silica.

Authors: Zeynep Zubeyde Altindag; Terken Baydar; Askin Isimer; Gonul Sahin
Journal: Int Arch Occup Environ Health Date: 2003-02-26 Impact factor: 3.015

9. Extranodal tumor extension to adjacent organs predicts a worse cause-specific survival in patients with papillary thyroid carcinoma.

Authors: Yasuhiro Ito; Mitsuyoshi Hirokawa; Tomoo Jikuzono; Takuya Higashiyama; Yuuki Takamura; Akihiro Miya; Kaoru Kobayashi; Fumio Matsuzuka; Kanji Kuma; Akira Miyauchi
Journal: World J Surg Date: 2007-06 Impact factor: 3.282

10. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.

Authors: C Huber; J R Batchelor; D Fuchs; A Hausen; A Lang; D Niederwieser; G Reibnegger; P Swetly; J Troppmair; H Wachter
Journal: J Exp Med Date: 1984-07-01 Impact factor: 14.307

3 in total